Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
+13.3%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$14.9B
AUM Growth
+$284M
(+1.9%)
Cap. Flow
-$1.11B
Cap. Flow
% of AUM
-7.49%
Top 10 Holdings %
Top 10 Hldgs %
15.7%
Holding
672
New
151
Increased
108
Reduced
135
Closed
187
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$239M |
| 2 |
Estee Lauder
EL
|
+$183M |
| 3 |
Autodesk
ADSK
|
+$172M |
| 4 |
Texas Instruments
TXN
|
+$154M |
| 5 |
Dollar General
DG
|
+$149M |
Top Sells
| 1 |
Boeing
BA
|
+$234M |
| 2 |
lululemon athletica
LULU
|
+$203M |
| 3 |
Analog Devices
ADI
|
+$198M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$187M |
| 5 |
Hershey
HSY
|
+$131M |
Sector Composition
| 1 | Technology | 23.28% |
| 2 | Consumer Discretionary | 14.47% |
| 3 | Healthcare | 14.33% |
| 4 | Industrials | 12.3% |
| 5 | Financials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Civitas Resources
CIVI
$3.11B
| $3M | 0.02% |
+43,940
| New | +$3M |
|
327
Nkarta
NKTX
$151M
| $2.97M | 0.02% |
450,731
-549,269
| -55% | -$3.63M |
|
328
Baxter International
BAX
$12.4B
| $2.94M | 0.02% |
76,161
-2,345,961
| -97% | -$90.7M |
|
329
Credo Technology Group
CRDO
$25.8B
| $2.87M | 0.02% |
+147,528
| New | +$2.87M |
|
330
CommScope
COMM
$3.59B
| $2.82M | 0.02% |
+1,000,000
| New | +$2.82M |
|
331
Acumen Pharmaceuticals
ABOS
$87.2M
| $2.82M | 0.02% |
733,203
+119,381
| +19% | +$458K |
|
332
P3 Health Partners
PIII
$28.7M
| $2.76M | 0.02% |
39,193
| – | – |
|
333
Crinetics Pharmaceuticals
CRNX
$3.31B
| $2.72M | 0.02% |
76,575
+7,073
| +10% | +$252K |
|
334
Latham Group
SWIM
$951M
| $2.66M | 0.02% |
1,012,502
| – | – |
|
335
Gossamer Bio
GOSS
$630M
| $2.66M | 0.02% |
2,913,216
-3,890,284
| -57% | -$3.55M |
|
336
Ameriprise Financial
AMP
$46.4B
| $2.64M | 0.02% |
6,962
+2,888
| +71% | +$1.1M |
|
337
Sagimet Biosciences
SGMT
$229M
| $2.64M | 0.02% |
486,560
+246,531
| +103% | +$1.34M |
|
338
Immunovant
IMVT
$2.85B
| $2.6M | 0.02% |
+61,820
| New | +$2.6M |
|
|
339
Analog Devices
ADI
$122B
| $2.58M | 0.02% |
12,978
-995,392
| -99% | -$198M |
|
340
GDS Holdings
GDS
$6.56B
| $2.52M | 0.02% |
276,275
-342,230
| -55% | -$3.12M |
|
341
Atlas Energy Solutions
AESI
$1.32B
| $2.49M | 0.02% |
144,612
-35,980
| -20% | -$620K |
|
342
Celestica
CLS
$28.1B
| $2.43M | 0.02% |
+83,039
| New | +$2.43M |
|
|
CYBN
343
Cybin
CYBN
$148M
| $2.33M | 0.02% |
+149,558
| New | +$2.33M |
|
344
Treace Medical Concepts
TMCI
$449M
| $2.32M | 0.02% |
182,112
+32,746
| +22% | +$418K |
|
345
MeiraGTx Holdings
MGTX
$601M
| $2.32M | 0.02% |
330,182
| – | – |
|
346
Wabtec
WAB
$32.6B
| $2.2M | 0.01% |
17,323
-294,462
| -94% | -$37.4M |
|
347
Janux Therapeutics
JANX
$1.49B
| $2.12M | 0.01% |
197,490
+22,490
| +13% | +$241K |
|
|
UBX
348
DELISTED
Unity Biotechnology
UBX
| $2.01M | 0.01% |
1,041,331
+1,002,636
| +2,591% | +$1.94M |
|
349
Nektar Therapeutics
NKTR
$924M
| $1.99M | 0.01% |
234,618
+145,837
| +164% | +$1.24M |
|
350
Grid Dynamics Holdings
GDYN
$665M
| $1.96M | 0.01% |
+146,985
| New | +$1.96M |
|